Clinical trial · Interventional
ESWT for Shoulder Pain in Patients With Brain Damage
The Effects of Extracorporeal Shockwave Therapy (ESWT) for Shoulder Pain in Patients With Brain Damage
NCT04320108CI-TRIAL-00091212completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aimed to investigate the efficacy and safety of extracorporeal shockwave therapy (ESWT) for upper extremity pain related to spasticity in patients with spinal cord injury.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Damage, Hypoxic | — | UNRESOLVED | — |
| Brain Tumor | Brain Neoplasm | ALIAS | 0.90 |
| ICH | — | UNRESOLVED | — |
| Stroke | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Extracorporeal shockwave therapy | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Experimental group
- description
- 3,000 pulses per time, low energy under 0.3 mJ/mm\^2, tolerable range
- interventionNames
- Device: Extracorporeal shockwave therapy
- type
- SHAM_COMPARATOR
- label
- Control group
- description
- Sham therapy
- interventionNames
- Device: Extracorporeal shockwave therapy
Primary outcomes (1)
- measure
- Numerical rating scale (NRS)
- timeFrame
- Up to 4 weeks (baseline, after each treatment during 2 weeks, 2 weeks + 1 day, 4 weeks)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * Brain damaged patient confirmed in the brain image * 1 month after brain damage * Pain in hemiplegic shoulder areas more than 4 points on the numerical scale (NRS) * Cognitive functions that can clearly point out NRS with more than 15 points in the mini mental state examination (MMSE) * Age: 20 and older * Person who has agreed in writing to decide his or her participation and comply with the precautions Exclusion Criteria: * Pain due to trauma * Injection treatments two weeks before participating in the study * Severe coagulopathy (excluding antiplatelet use) * Impaired cognition
References
Publications (0)
Data not yet available
No reference posted for this study.